Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Advancing Pregnenolone as a Novel Therapy for Co-Occurring Cannabis Use Disorder and Depression

NCT07685964 is registered in ClinicalTrials.gov with University of Texas Southwestern Medical Center as lead sponsor.

NCT NCT07685964
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07685964 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Advancing Pregnenolone as a Novel Therapy for Co-Occurring Cannabis Use Disorder and Depression
Lead sponsor
University of Texas Southwestern Medical Center
Phase
Phase 1/2
Overall status
Not yet recruiting
Start date
September 30, 2026
Completion date
August 31, 2028
Enrollment
20 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cannabis use disorder, major depressive disorder (mdd)